...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure

I thought it interesting that management (ok...Don) chose to address the question of a US listing.  He said that they didn't need to do that at this time because there were/are other options available to them.  Almost certainly those other options are the 1,2,& 3 Options he outlined a few short months ago.  Nevertheless, he held open the possibility of going down the US listing road should circumstances warrant or dictate.

It is difficult to know exactly what to read into the above, but since this is a forum for spitballing I suppose this is a possibility.  They know that a deal is close and, failing that, Options 2 & 3 are still out there.  If Option 1 (the partnering, etc.) comes to fruition then would this not also increase the liklihood of a full buyout within a year or two thereafter?  If so, then why bother with a US listing at this stage?  Is Don giving us a clue to what might transpire?  If it's Options 2 or 3 then does the liklihood of a US listing increase?  We don't have the answers but I'd be interested in knowing if anyone thinks this theory has merit.

Share
New Message
Please login to post a reply